Morocco Plans to Manufacture a Cannabis-Derived Medication for Children

Morocco is preparing to enter a new phase in the utilization of cannabis for medical purposes by manufacturing a specialized medication for children derived from this plant. This initiative reflects Morocco’s commitment to using cannabis for therapeutic purposes in accordance with strict scientific and medical standards.

This initiative is part of Morocco’s strategy to develop the pharmaceutical industry related to cannabis, especially after its cultivation was legalized for medical and industrial purposes. The project aims to produce medications based on cannabis extracts, which have proven effective in treating various conditions, particularly for children suffering from epilepsy and neurological disorders.

Scientific studies indicate that the cannabinoids found in cannabis possess therapeutic properties that help alleviate chronic pain, reduce epileptic seizures, and improve the quality of life for patients with complex neurological disorders. Through this approach, Morocco seeks to harness these medicinal properties by producing safe and effective drugs developed in accordance with international standards.

Morocco is among the first Arab and African countries to adopt the use of cannabis for medical purposes, following its legalization in 2021. As one of the world’s largest producers of this plant, the country has an opportunity to develop an advanced pharmaceutical industry based on scientific research and medical technology.

Despite the significant opportunities this project presents, there are legal and logistical challenges to overcome, such as ensuring strict control over production and distribution and guaranteeing that this industry serves the healthcare sector without any potential deviations.

Nevertheless, with its expertise and capabilities, Morocco is well-positioned to make a significant breakthrough in the field of cannabis-derived pharmaceuticals. This could establish the country as a leading model in the region, particularly in the production of pediatric medicines that will contribute to improving the lives of many young patients.

Source: Fes News